Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model
Peripheral nerve injury leads to sensory ganglion hyperexcitation, which increases neurotransmitter release and neuropathic pain. Botulinum toxin type A (BoNT/A) regulates pain transmission by reducing neurotransmitter release, thereby attenuating neuropathic pain. Despite multiple studies on the us...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Toxins |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6651/13/10/704 |
| _version_ | 1797513088894763008 |
|---|---|
| author | Arief Waskitho Yumiko Yamamoto Swarnalakshmi Raman Fumiya Kano Huijiao Yan Resmi Raju Shaista Afroz Tsuyoshi Morita Daisuke Ikutame Kazuo Okura Masamitsu Oshima Akihito Yamamoto Otto Baba Yoshizo Matsuka |
| author_facet | Arief Waskitho Yumiko Yamamoto Swarnalakshmi Raman Fumiya Kano Huijiao Yan Resmi Raju Shaista Afroz Tsuyoshi Morita Daisuke Ikutame Kazuo Okura Masamitsu Oshima Akihito Yamamoto Otto Baba Yoshizo Matsuka |
| author_sort | Arief Waskitho |
| collection | DOAJ |
| description | Peripheral nerve injury leads to sensory ganglion hyperexcitation, which increases neurotransmitter release and neuropathic pain. Botulinum toxin type A (BoNT/A) regulates pain transmission by reducing neurotransmitter release, thereby attenuating neuropathic pain. Despite multiple studies on the use of BoNT/A for managing neuropathic pain in the orofacial region, its exact mechanism of transport remains unclear. In this study, we investigated the effects of BoNT/A in managing neuropathic pain in two different animal models and its transport mechanism in the trigeminal nerve. Intraperitoneal administration of cisplatin induced bilateral neuropathic pain in the orofacial region, reducing the head withdrawal threshold to mechanical stimulation. Unilateral infraorbital nerve constriction (IONC) also reduced the ipsilateral head withdrawal threshold to mechanical stimulation. Unilateral peripheral administration of BoNT/A to the rat whisker pad attenuated cisplatin-induced pain behavior bilaterally. Furthermore, contralateral peripheral administration of BoNT/A attenuated neuropathy-induced behavior caused by IONC. We also noted the presence of BoNT/A in the blood using the mouse bioassay. In addition, the Alexa Fluor-488-labeled C-terminal half of the heavy chain of BoNT/A (BoNT/A-Hc) was localized in the neurons of the bilateral trigeminal ganglia following its unilateral administration. These findings suggest that axonal and hematogenous transport are involved in the therapeutic effects of peripherally administered BoNT/A in the orofacial region. |
| first_indexed | 2024-03-10T06:10:46Z |
| format | Article |
| id | doaj.art-bfefe539246c4f49b7474bab5a56a858 |
| institution | Directory Open Access Journal |
| issn | 2072-6651 |
| language | English |
| last_indexed | 2024-03-10T06:10:46Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Toxins |
| spelling | doaj.art-bfefe539246c4f49b7474bab5a56a8582023-11-22T20:13:11ZengMDPI AGToxins2072-66512021-10-01131070410.3390/toxins13100704Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal ModelArief Waskitho0Yumiko Yamamoto1Swarnalakshmi Raman2Fumiya Kano3Huijiao Yan4Resmi Raju5Shaista Afroz6Tsuyoshi Morita7Daisuke Ikutame8Kazuo Okura9Masamitsu Oshima10Akihito Yamamoto11Otto Baba12Yoshizo Matsuka13Department of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Bacteriology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Tissue Regeneration, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Oral Disease Research, National Center for Geriatrics and Gerontology, Obu 474-8511, JapanDepartment of Prosthodontics, ZA Dental College, Aligarh Muslim University, Aligarh 202002, IndiaDepartment of Oral and Maxillofacial Anatomy, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Tissue Regeneration, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Oral and Maxillofacial Anatomy, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanDepartment of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, JapanPeripheral nerve injury leads to sensory ganglion hyperexcitation, which increases neurotransmitter release and neuropathic pain. Botulinum toxin type A (BoNT/A) regulates pain transmission by reducing neurotransmitter release, thereby attenuating neuropathic pain. Despite multiple studies on the use of BoNT/A for managing neuropathic pain in the orofacial region, its exact mechanism of transport remains unclear. In this study, we investigated the effects of BoNT/A in managing neuropathic pain in two different animal models and its transport mechanism in the trigeminal nerve. Intraperitoneal administration of cisplatin induced bilateral neuropathic pain in the orofacial region, reducing the head withdrawal threshold to mechanical stimulation. Unilateral infraorbital nerve constriction (IONC) also reduced the ipsilateral head withdrawal threshold to mechanical stimulation. Unilateral peripheral administration of BoNT/A to the rat whisker pad attenuated cisplatin-induced pain behavior bilaterally. Furthermore, contralateral peripheral administration of BoNT/A attenuated neuropathy-induced behavior caused by IONC. We also noted the presence of BoNT/A in the blood using the mouse bioassay. In addition, the Alexa Fluor-488-labeled C-terminal half of the heavy chain of BoNT/A (BoNT/A-Hc) was localized in the neurons of the bilateral trigeminal ganglia following its unilateral administration. These findings suggest that axonal and hematogenous transport are involved in the therapeutic effects of peripherally administered BoNT/A in the orofacial region.https://www.mdpi.com/2072-6651/13/10/704botulinum toxintrigeminal ganglionneuropathic pain |
| spellingShingle | Arief Waskitho Yumiko Yamamoto Swarnalakshmi Raman Fumiya Kano Huijiao Yan Resmi Raju Shaista Afroz Tsuyoshi Morita Daisuke Ikutame Kazuo Okura Masamitsu Oshima Akihito Yamamoto Otto Baba Yoshizo Matsuka Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model Toxins botulinum toxin trigeminal ganglion neuropathic pain |
| title | Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model |
| title_full | Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model |
| title_fullStr | Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model |
| title_full_unstemmed | Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model |
| title_short | Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model |
| title_sort | peripherally administered botulinum toxin type a localizes bilaterally in trigeminal ganglia of animal model |
| topic | botulinum toxin trigeminal ganglion neuropathic pain |
| url | https://www.mdpi.com/2072-6651/13/10/704 |
| work_keys_str_mv | AT ariefwaskitho peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT yumikoyamamoto peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT swarnalakshmiraman peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT fumiyakano peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT huijiaoyan peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT resmiraju peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT shaistaafroz peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT tsuyoshimorita peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT daisukeikutame peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT kazuookura peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT masamitsuoshima peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT akihitoyamamoto peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT ottobaba peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel AT yoshizomatsuka peripherallyadministeredbotulinumtoxintypealocalizesbilaterallyintrigeminalgangliaofanimalmodel |